HIVClinicalForum
Meeting category
Date(s)
21 Jul 2018
Location
Amsterdam, Netherlands
Organizer

Global HIV Clinical Forum 2018

Related Enduring Materials

Enduring Materials
Session 1: Update on Clinical Management using Integrase Inhibitors -
State of the ART: Integrase Inhibitors Resistance (Not yet available)
Jeroen van Kampen
Jeroen van Kampen, MD, PhD
Erasmus Medical Center, Rotterdam, The Netherlands
State of the ART: Integrase Inhibitors (clinical overview)
Mauro Schechter, MD, PhD
Federal University of Rio de Janeiro, Brazil
Clinical case presentation (Not available)
Charles Boucher, MD, PhD
Erasmus Medical Center, The Netherlands
Jeroen van Kampen
Jeroen van Kampen, MD, PhD
Erasmus Medical Center, Rotterdam, The Netherlands
Session 2: Changing the paradigm: Is reducing drug regimen an option? -
What is the Clinical support for reduce drug regimens?
Anton Pozniak, MD, FRCP
Chelsea and Westminster Hospital, United Kingdom
What is the Virological support for reduced drug regimens?
Daniel Kuritzkes, MD
Brigham and Women's Hospital / Harvard Medical School, United States
What is the Pharmacological support for reduce drug regimens?
David Back, PhD
University of Liverpool, United Kingdom
Session 3: Use of Integrase Inhibitors in special patient populations -
Expanding Integrase Inhibitors in the rest of Europe
Miłosz Parczewski, MD, PhD
Pomeranian Medical University, Szczecin, Poland
Integrase Inhibitors in children (Not yet available)
Natella Rakhmanina, MD, PhD, FAAP, FCP, AAHIVS
Children’s National Hospital, United States
Implication of the resent Dolutegravir data
Rebecca Zash, MD
Beth Israel Deaconess Medical Center, Harvard Medical School, United Kingdom
Clinical case: Integrase Inhibitors in Africa
Julia Turner
Julia Turner, MD
Right to Care, Johannesburg, South Africa
Session 4: Novel treatment strategies / delivery systems -
Designing e-health interventions for HIV care
Guido van den Berk, MD, PhD
OLVG Hospital, the Netherlands
One pill a day?: Integration novel delivery systems into routine care
Terry Blaschke
Terry Blaschke, MD
Bill & Melinda Gates Foundation, Stanford, CA, USA
Overview
Welcome

We would like to thank you for joining us at the Global HIV Clinical Forum 2018 in Amsterdam, preceding AIDS2018. It was a wonderful meeting filled with lively discussions and great presentations from speakers around the world.

Background

The HIV CLINICAL FORUM is developed as part of a series of interactive programs that provide independent medical education on emerging topics in HIV. The program features International and regions experts in order to provide HIV clinicians and allied healthcare professionals with updates on the latest developments related to HIV management, providing opportunities for sharing of clinical experience and presenting results from ongoing and completed cohorts/research programs.

Program Chairs
Support
Endorsers